Philips Respironics finalizes a consent decree with US DOJ and FDA for its US business operations.
Philips Respironics reaches a final agreement with the US DOJ and FDA on a consent decree. The decree focuses on Philips' US business operations and provides clarity and a roadmap for demonstrating compliance with regulatory requirements. Philips is committed to meeting the decree's requirements while continuing to serve healthcare providers and patients. The 2025 Group financial outlook remains unchanged.
April 10, 2024
3 Articles